Aurobindo Pharma saw no growth in patent filings and highest growth of 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Aurobindo Pharma’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Aurobindo Pharma has been focused on protecting inventions in United States(US) with two publications in Q2 2024
The United States(US) Patent Office dominates the patent grants with nearly 100% of grants. The United States(US) patent Office are among the top ten patent offices where Aurobindo Pharma is filings its patents. Among the top granted patent authorities, Aurobindo Pharma has 100% of its grants in United States(US).
Eli Lilly and Co could be the strongest competitor for Aurobindo Pharma
Patents related to addiction and rare diseases lead Aurobindo Pharma's portfolio
Aurobindo Pharma has the highest number of patents in addiction followed by, rare diseases. For addiction no patents were filed and 50% of patents were granted in Q2 2024.
Chorea related patents lead Aurobindo Pharma portfolio followed by tardive dyskinesia, and huntington disease
Aurobindo Pharma has highest number of patents in chorea followed by tardive dyskinesia, huntington disease, mobiles, hand-helds, pdas, smartphones.
For comprehensive analysis of Aurobindo Pharma's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
